Place it in its market
Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.
See how Context works →On the price, the facts of the public record◆Adverse 8-K filing◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account
End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.
Latest on record
The most recent facts, as filed.
Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.
- Sep 29, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 18, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
- Aug 14, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
In numbers
What this profile holds, counted.
Closes · 1 year210
SEC filings on record10110 flagged findings
Reported transactions (Form 4)2since Jun 24, 2026 · and 5 other holdings
Corporate events (8-K)27since May 6, 2025
What the record says
Description, identity and filings, each with its source.
Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.
Listing notice in force
The exchange has notified the company that it fails a continued-listing requirement (8-K, item 3.01 of Sep 29, 2026).
Deadline: May 18, 2026 · passed
- market value of publicly held shares · Nasdaq, rule 5450(b)(2)(A) · notice of Nov 19, 2025 · delisting determination · deadline May 18, 2026 (text and rule agree) · first period expired; a second 180-day period may exist that is not on record
Reverse splits in 5 years
1 reverse split in 5 years (1:50 on Aug 21, 2026) · 1:50 cumulative
The other times: of 785 securities that did their first reverse split in 5 years, a year later the median was worth 0.54× the price on the day of the split; 364 lost more than half and 204 rose (783 with a price a year later).
Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.
The 25 most recent filings (of 101)
Every SEC filing, newest first, with what it is. Below, each type with its own explanation.
- Sep 29, 268-K ↗Current report · Listing notice (8-K 3.01)
- Aug 18, 268-K ↗Current report · Listing notice (8-K 3.01)
- Aug 14, 2610-Q ↗Quarterly report
- Aug 4, 268-K ↗Current report · Shareholder vote results
- Jul 30, 268-K ↗Current report · Other events
- Jul 24, 268-K ↗Current report · Listing notice (8-K 3.01)
- Jul 22, 26SCHEDULE 13G ↗Passive stake · Samda Biolab Co., Ltd. · 5.1% · event on Jul 2, 26
- Jul 14, 26Form 4 ↗Insider transaction
- Jul 14, 26SCHEDULE 13D/A ↗Stake with intent to influence · Valetudo Therapeutics LLC · 14.3% · event on Jul 2, 26 · amendment
- Jul 13, 26DEF 14A ↗Shareholder meeting and votes
- Jul 6, 26Form 4 ↗Insider transaction
- Jul 6, 26Form 3 ↗Insider transaction
- Jul 6, 26SCHEDULE 13G/A ↗Passive stake · Ewon Comfortech Co., Ltd. · 10.9% · event on Jun 24, 26 · amendment
- Jul 6, 268-K ↗Current report · Sold unregistered shares
- Jun 30, 26PRE 14A ↗Shareholder meeting and votes
- Jun 24, 26S-1 ↗Securities offering
- Jun 3, 268-K ↗Current report · Entered a material agreement
- Jun 3, 26424B3 ↗Securities offering
- May 27, 268-K ↗Current report · Listing notice (8-K 3.01)
- May 20, 268-K ↗Current report · Entered a material agreement
- May 15, 2610-Q ↗Quarterly report
- Mar 31, 2610-K ↗Annual report
- Mar 4, 268-K ↗Current report · Bylaws or fiscal year change
- Feb 20, 26SCHEDULE 13G ↗Passive stake · Mitchell P. Kopin · 5.0% · event on Feb 17, 26
- Feb 18, 268-K ↗Current report · Entered a material agreement
101 filings on record, the oldest from May 30, 23.
Listing the 25 most recent filings of the 101 on record.
8154
3 listing notices2026show all 3hide
- Sep 29, 26Listing notice (8-K 3.01)+2 more in the same filing · the same filing reports the recovery8-K 3.01 ↗
- Aug 18, 26Listing notice (8-K 3.01)+4 more in the same filing · the same filing reports the recovery8-K 3.01 ↗
- Jul 24, 26Listing notice (8-K 3.01)+2 more in the same filing8-K 3.01 ↗
- Jul 6, 26Sold unregistered shares+4 more in the same filing8-K 3.02 ↗
- Jun 3, 26Entered a material agreement+4 more in the same filing8-K 1.01 ↗
- May 27, 26Listing notice (8-K 3.01)+1 more in the same filing · the filing reports the decision to delist8-K 3.01 ↗
- May 20, 26Entered a material agreement+1 more in the same filing8-K 1.01 ↗
- Feb 18, 26Entered a material agreement+2 more in the same filing8-K 1.01 ↗
- Feb 9, 26Sold unregistered shares+2 more in the same filing8-K 3.02 ↗
3 listing notices2025 – 2026show all 3hide
- Jan 26, 26Listing notice (8-K 3.01)8-K 3.01 ↗
- Nov 25, 25Listing notice (8-K 3.01)8-K 3.01 ↗
- Aug 25, 25Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Jul 17, 25Sold unregistered shares+1 more in the same filing8-K 3.02 ↗
- Jul 11, 25A senior executive left or was appointed8-K 5.02 ↗
- Jun 4, 25Listing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
- Jun 2, 25Completed an acquisition or disposal+1 more in the same filing8-K/A 2.01 ↗
1 older filings not shown
Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.
Schedule 13D: stake and stated purpose
Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.
- Iris Acquisition Holdings LLC26.5%Apr 30, 25SCHEDULE 13D ↗
- Valetudo Therapeutics LLC14.3%Jul 2, 26SCHEDULE 13D/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
Schedule 13G: short-form filing
The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.
- KH Feelux Co., Ltd15.4%Apr 30, 25SCHEDULE 13G ↗
- Ewon Comfortech Co., Ltd.10.9%Jun 24, 26SCHEDULE 13G/A ↗1 earlier filing
- Red Peony Association 1st5.7%Apr 30, 25SCHEDULE 13G ↗
- Nongae Apple Association 1st5.7%Apr 30, 25SCHEDULE 13G ↗
- Samda Biolab Co., Ltd.5.1%Jul 2, 26SCHEDULE 13G ↗
show one more holderhide
- Mitchell P. Kopin5.0%Feb 17, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.
No purchases or sales are on record in this stretch; only other transactions (compensation, withholding, exercises or gifts).
Stock compensation, tax and giftsshow the 2 other transactionshide
Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.
The full record holds 2 transactions and goes back to Apr 30, 25.
Its sector and its market
Liminatus Pharma Inc. among Health Care companies
The profile shows what is on record. Context and Radar place the company among those of its sector and region.
Browse its neighbours
Other Health Care companies
With an account you also get
- The four engines — growth, trend, risk and context — each with its word and its score.
- The risk band and the sector phase.
- The company's fundamentals and accounts.
- Watchlist: your list of companies, with the «since you follow it» figure.
The research continues
The profile tells the story. The market sets the scene.
From Liminatus Pharma Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.
See what deserves a closer look
Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.
See how Radar works →Keep the why
Follow Liminatus Pharma Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.
See an example review →
Coverage
What sits behind this page.
Where each figure comes from and how far it reaches.
- Prices
- End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
- Series quality
- Series with incidents in the period; the chart shows what could be kept.
- SEC records
- 101 documents on file, from May 30, 2023 to Sep 29, 2026.
- Company description
- No description available.
- This page
- Generated on Oct 19, 2026; refreshed through the day.
Start at your own pace
Explore first. Go deeper with access.
Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.
Compare plans →- No account
This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.
- Pro
What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.
- Pro+
Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.
Are the prices real time?
No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.
Which SEC documents appear here?
Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.
Why does a European company show no SEC records?
It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.
Before forming a view on a company,
read what is on record.
One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.